Mettler-Toledo’s second-quarter performance surpassed Wall Street’s expectations on both revenue and adjusted earnings, but ...

Vertex Pharmaceuticals’ second quarter 2025 results exceeded Wall Street’s expectations, but the market responded sharply negatively. Management pointed to strong commercial execution in its cystic ...